dehydroepiandrosterone has been researched along with bicalutamide in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Eri, LM; Haug, E; Tveter, KJ | 1 |
Araki, H; Hara, T; Kusaka, M; Nakamura, K; Yamaoka, M | 1 |
Arnold, JT; Blackman, MR; Le, H; McFann, KK | 1 |
Allen, JD; Arnold, JT; Blackman, MR; Le, H; Liu, X; McFann, KK | 1 |
Jauhiainen, M; Mervaala, E; Paatela, H; Tikkanen, MJ; Vihma, V | 1 |
Anai, S; Fujimoto, K; Miyake, M; Nakai, Y; Tanaka, N; Tatsumi, Y | 1 |
2 trial(s) available for dehydroepiandrosterone and bicalutamide
Article | Year |
---|---|
Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia.
Topics: Aged; Androgen Antagonists; Androstenedione; Anilides; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Double-Blind Method; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Nitriles; Prolactin; Prostatic Hyperplasia; Testosterone; Tosyl Compounds | 1995 |
A Randomized Control Trial Comparing the Efficacy of Antiandrogen Monotherapy: Flutamide vs. Bicalutamide.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androstenedione; Anilides; Dehydroepiandrosterone; Flutamide; Humans; Male; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2015 |
5 other study(ies) available for dehydroepiandrosterone and bicalutamide
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
Topics: Androgen Antagonists; Androgens; Anilides; Animals; Cell Division; Dehydroepiandrosterone; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Hormone-Dependent; Nitriles; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Tosyl Compounds; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
Topics: Androgen Antagonists; Anilides; Cell Proliferation; Cells, Cultured; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Flutamide; Gene Expression; Humans; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Middle Aged; Nitriles; Prostate; Receptor, IGF Type 1; Stromal Cells; Testosterone; Tosyl Compounds | 2006 |
Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Anilides; Cell Division; Cell Line, Tumor; Dehydroepiandrosterone; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Fulvestrant; Gene Expression; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; RNA, Small Interfering; Testosterone; Tosyl Compounds | 2007 |
Dehydroepiandrosterone fatty acyl esters in high density lipoprotein: interaction with human vascular endothelial cells and vascular responses ex vivo.
Topics: Androgen Receptor Antagonists; Anilides; Animals; Cells, Cultured; Cyclopentanes; Dehydroepiandrosterone; Endothelial Cells; Esters; Estrogen Antagonists; Female; Humans; In Vitro Techniques; Lipoproteins, HDL; Male; Mesenteric Arteries; Nitriles; Rats; Rats, Wistar; Receptors, Lipoprotein; Thiosemicarbazones; Tosyl Compounds; Vasodilator Agents | 2011 |